Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy-Reference-Cited by-同舟云学术

Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy

Published:2021-09 Issue:18 Volume:184 Page:4753-4771.e27
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Koikawa Kazuhiro^ORCID,Kibe Shin,Suizu Futoshi,Sekino Nobufumi^ORCID,Kim Nami,Manz Theresa D.,Pinch Benika J.,Akshinthala Dipikaa,Verma Ana^ORCID,Gaglia Giorgio^ORCID,Nezu Yutaka,Ke Shizhong,Qiu Chenxi,Ohuchida Kenoki^ORCID,Oda Yoshinao,Lee Tae Ho,Wegiel Babara,Clohessy John G.,London Nir,Santagata Sandro,Wulf Gerburg M.^ORCID,Hidalgo Manuel,Muthuswamy Senthil K.^ORCID,Nakamura Masafumi,Gray Nathanael S.^ORCID,Zhou Xiao Zhen,Lu Kun Ping

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference104 articles.

1. Pancreatic Cancer Chemoresistance to Gemcitabine;Amrutkar;Cancers (Basel),2017

2. Pin1 is a novel prognostic marker in prostate cancer;Ayala;Cancer Research,2003

3. Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells;Bachem;Gastroenterology,2005

4. Broadening the Impact of Immunotherapy to Pancreatic Cancer: Challenges and Opportunities;Balachandran;Gastroenterology,2019

5. Prevalent overexpression of prolyl isomerase Pin1 in human cancers;Bao;Am. J. Pathol.,2004

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integration of single-nucleus and exosome RNA sequencing dissected inter-cellular communication and biomarkers in pancreatic ductal adenocarcinoma;Computational and Structural Biotechnology Journal;2024-12

2. Unveiling the resistance to therapies in pancreatic ductal adenocarcinoma;Drug Resistance Updates;2024-11

3. Unlocking the potential: Targeting metabolic pathways in the tumor microenvironment for Cancer therapy;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

4. The aminophospholipid transporter, ATP8B3, as a potential biomarker and target for enhancing the therapeutic effect of PD-L1 blockade in colon adenocarcinoma;Genomics;2024-09

5. Unveiling the functional roles of patient‐derived tumour organoids in assessing the tumour microenvironment and immunotherapy;Clinical and Translational Medicine;2024-09